Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
DSM-Firmenich AG - SIC # 2819 - INDUSTRIAL INORGANIC CHEMICALS, NOT ELSEWHERE CLASSIFIED
Ticker
Exchange
SIC #
Website
Latest Ticker
DSFIY
Over the counter
2819
www.dsm-firmenich.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for DSM-Firmenich AG
dsm-firmenich shares commence trading on SIX Swiss Exchange, establishing dual listing with Euronext Amsterdam
- May 20th, 2026 11:00 pm
Weekly progress on share repurchase program to cover share plans and reduce capital
- May 18th, 2026 11:00 pm
DSM-Firmenich Medisca Deal Highlights U.S. Vitamin API And Valuation Upside
- May 14th, 2026 7:20 am
Folic Acid Industry Research Report 2026: Surging Demand in Emerging Markets and Aging Populations, & Expanding Role in Chronic Disease Prevention Bolster Growth - Global Forecast to 2030
- May 12th, 2026 8:38 am
Tocopherols Market Analysis Report 2026: Increasing Demand for Natural Antioxidants and Vitamin E in Food, Pharmaceuticals, and Cosmetic Products Bolster Growth - Global Forecast to 2030
- May 12th, 2026 7:46 am
dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2026
- May 7th, 2026 4:35 am
Dividend Investors: Don't Be Too Quick To Buy DSM-Firmenich AG (AMS:DSFIR) For Its Upcoming Dividend
- May 6th, 2026 10:07 pm
dsm-firmenich Q1 2026 trading update
- May 5th, 2026 11:00 pm
Assessing DSM-Firmenich (ENXTAM:DSFIR) Valuation After Recent Share Price Swings
- Mar 13th, 2026 5:12 am
dsm-firmenich announces share repurchase program to cover share plans and reduce capital
- Mar 12th, 2026 12:00 am
dsm-firmenich outlines action plan at Investor Event to accelerate performance, following completion of transformation
- Mar 12th, 2026 12:00 am
dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program
- Feb 25th, 2026 11:00 pm
dsm-firmenich publishes 2025 Integrated Annual Report
- Feb 19th, 2026 11:00 pm
dsm-firmenich issues €1.5 billion long-term bonds
- Feb 16th, 2026 11:00 pm
DSM-Firmenich AG (AMS:DSFIR) Analysts Are Reducing Their Forecasts For This Year
- Feb 14th, 2026 11:36 pm
DSM-Firmenich AG (DSMFF) Full Year 2025 Earnings Call Highlights: Navigating Growth Amid Market ...
- Feb 12th, 2026 8:00 am
dsm-firmenich reports full year 2025 results
- Feb 11th, 2026 11:00 pm
Assessing DSM Firmenich (ENXTAM:DSFIR) Valuation After Recent Share Price Rebound
- Feb 10th, 2026 1:13 pm
dsm-firmenich provides preliminary comparative figures following the announced divestment of Animal Nutrition & Health (ANH)
- Feb 9th, 2026 4:29 am
dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners
- Feb 8th, 2026 11:00 pm
Scroll